Travelers’ diarrhea drug, Aemcolo, receives FDA nod
by Press Release from Outbreak News Today on (#4347Q)
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. "Travelers' diarrhea affects millions of people each year and having treatment options for this ["]
The post Travelers' diarrhea drug, Aemcolo, receives FDA nod appeared first on Outbreak News Today.